Archer Investment Series Trust NPORT-P Archer Dividend Growth Fund (Nov 2020 report)

Schedule of Investments
November 30, 2020 (unaudited)
Archer Dividend Growth Fund
		Shares or Principal
Security Description		Amount ($)		Fair Value ($)(1)
Common Stocks - 12.30%
Beverages - 1.95%
PepsiCo, Inc.		2,500		360,575
Biotech & Phamaceutical - 1.52%
Viatris Inc (2)		16,700		280,892
Canned, Fruits, Veg & Preserves, Jams & Jellies - 2.47%
J.M. Smucker Co.		3,900		457,080
Computer & Office Equipment - 2.40%
Cisco Systems, Inc.		10,300		443,106
Computer Storage Devices - 2.23%
Seagate Technology Plc. (Ireland)		7,000		411,670
Construction Machinery & Equip - 2.28%
Caterpillar Inc.		2,425		420,956
Converted Paper & Paperboard Prods (No Containers/Boxes) - 2.19%
Kimberly Clark Corp.		2,900		403,999
Electric & Other Services Combined - 6.41%
Consolidated Edison, Inc.		5,350		407,938
Duke Energy Corp.		4,300		398,438
Exelon Corp.		9,200		377,844
				1,184,220
Electric Services - 6.73%
American Electric Power Co., Inc.		4,500		382,005
Entergy Corp.		3,900		424,515
Southern Co.		7,300		436,905
				1,243,425
Finance Services - 2.31%
Hercules Capital, Inc.		32,000		426,880
Guided Missiles & Space Vehicles & Parts - 1.98%
Lockheed Martin Corp.		1,000		365,000
Insurance Agents Brokers & Services - 2.75%
Arthur J. Gallagher & Co.		4,400		507,804
Misc Industrial & Commercial Machinery & Equipment - 2.56%
Eaton Corp., Plc. (Ireland)		3,900		472,329
National Commercial Banks - 5.29%
JPMorgan Chase & Co.		3,500		412,580
Regions Financial Corp.		37,000		564,990
				977,570
Natural Gas Transmission - 1.56%
Kinder Morgan, Inc.		20,000		287,600
Paper Mills - 2.59%
International Paper Co.		9,680		478,966
Petroleum Refining - 2.36%
Chevron Corp.		5,000		435,900
Pharmaceutical Preparations - 13.99%
AbbVie, Inc.		6,350		664,083
Bristol Myers Squibb Co.		5,225		326,040
GlaxoSmithKline Plc. ADR		8,100		297,999
Johnson & Johnson		2,500		361,700
Merck & Co., Inc.		5,100		409,989
Pfizer, Inc.		13,700		524,847
				2,584,658
Retail - Drug Stores - 1.63%
Walgreens Boots Alliance, Inc.		7,900		300,279
Retail-Drug Stores & Proprietary Stores - 2.35%
CVS Health Corp.		6,400		433,856
Search, Detection, Navigation, Guidance, Aeronautical Systems - 2.47%
Garmin Ltd. (Switzerland)		3,900		455,364
Semiconductors & Related Devices - 3.39%
Broadcom, Inc.		487		195,569
Texas Instruments, Inc.		2,670		430,538
				626,107
Services - Personal Services - 2.24%
H&R Block		22,000		413,600
Soap, Detergent, Cleaning Preparations, Perfumes, Cosmetics - 2.48%
Procter & Gamble Co.		3,300		458,271
Surgical & Medical Instruments & Apparatus - 0.99%
3M Co.		1,062		183,439
Telephone Communications (No Radio Telephone) - 4.19%
BCE, Inc.		7,400		320,864
Verizon Communications, Inc.		7,500		453,075
				773,939
Trucking & Courier Services - 3.47%
United Parcel Service, Inc. Class B		3,750		641,513
Total Common Stock		(Cost $             13,069,199)		16,028,998
Real Estate Investment Trust - 12.30%
American Campus Communities, Inc.		11,860		472,028
Crown Castle International Corp.		2,700		452,439
Digital Realty Trust, Inc.		3,400		458,150
Iron Mountain, Inc.		16,500		453,750
W. P. Carey, Inc.		6,300		436,023
Total Real Estate Investment Trusts		(Cost $                1,964,191)		2,272,390
Money Market Registered Investment Companies - 0.54%
Federated Treasury Obligation Fund - Institutional Shares - 0.01 % (3)		100,138		100,138
Total Money Market Registered Investment Companies		(Cost $                   100,138)		100,138
Total Investments - 99.62%		(Cost $               15,133,528)		18,401,526
Other Assets less Liabilities - .38%				70,807
Total Net Assets - 100.00%				18,472,333
(1)  Statement on Financial Accounting Standard No. 157 "Fair Value Measurements" - Various inputs are used in determining the value of the Fund's investments.
These inputs are summarized in the three broad levels listed below.
• Level 1 - quoted prices in active markets for identical securities
• Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.)
• Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments)
The following is a summary of the inputs used as of November 30, 2020 in valuing the Fund's assets carried at fair value:
		Investments in		Other Financial
Valuation Inputs		Securities		Instruments
Level 1 - Quoted Prices	$	18,401,526	$	0
Level 2 - Other Significant Observable Inputs		0		-
Level 3 - Significant Unobservable Inputs		-		-
Total	$	18,401,526	$	0
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term
debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment
Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active
market, such securities are reflected as Level 2.
(2)  Represents non-income producing securities.
(3)  Variable rate security; the coupon rate shown represents the yield at November 30, 2020.